Immunome IMNM

$ 10.9 -1.62%

Quarterly report 2024-Q3
added 11-13-2024

Immunome Financial Statements 2011-2024 | IMNM

Annual Financial Statements Immunome

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Market Cap	490 M	62.3 M	150 M	146 M	-	-	-	-	-	-	-	-	-
Shares	19.8 M	12.1 M	11.5 M	10 M	-	-	-	-	-	-	-	-	-
Historical Prices	24.7	5.14	13	9.68	-	-	-	-	-	-	-	-	-
Net Income	-107 M	-36.9 M	-24.7 M	-17.8 M	-10.4 M	-7.84 M	-	-	-	-	-	-	-
Revenue	14 M	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-110 M	-36.9 M	-25.2 M	-12.3 M	-10.3 M	-	-	-	-	-	-	-	-
Interest Expense	2.72 M	5 K	493 K	-5.58 M	-96 K	-	-	-	-	-	-	-	-
EBITDA	-109 M	-36.5 M	-24.4 M	-11.5 M	-9.73 M	-7.22 M	-	-	-	-	-	-	-
Operating Expenses	124 M	36.9 M	25.2 M	12.3 M	10.3 M	7.74 M	-	-	-	-	-	-	-
General and Administrative Expenses	19.7 M	13.6 M	11.1 M	4.78 M	1.52 M	866 K	-	-	-	-	-	-	-

All numbers in USD currency

Quarterly Income Statement Immunome

	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Shares	60.2 M	59.9 M	51.5 M	43.3 M	12.2 M	12.2 M	12.2 M	12.1 M	12.1 M	12.1 M	12.1 M	12.1 M	11.9 M	11.5 M	10.6 M	10.6 M	1.11 M	1.1 M	1.1 M	1.1 M	1.09 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	-47.1 M	-36.1 M	-129 M	-	-4.34 M	-5.56 M	-4.27 M	-	-8.53 M	-8.92 M	-11.7 M	-	-7.72 M	-5.24 M	-3.9 M	-	-8.38 M	-2.71 M	-2.68 M	-	-2.74 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Revenue	2.91 M	2.36 M	1.03 M	-	3.56 M	4.26 M	2.36 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-50.5 M	-40 M	-132 M	-	-4.63 M	-5.77 M	-4.47 M	-	-8.53 M	-8.93 M	-11.7 M	-	-7.72 M	-5.74 M	-3.9 M	-	-2.82 M	-2.72 M	-2.66 M	-	-2.72 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest Expense	3.42 M	3.89 M	2.81 M	-	288 K	216 K	201 K	-	1 K	2 K	1 K	-	-3 K	-1 K	-1 K	-	-10 K	5 K	-22 K	-	-17 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-132 M	-	-	-	-4.38 M	-	-8.21 M	-8.93 M	-11.5 M	-	-7.09 M	-5.74 M	-3.72 M	-	-2.32 M	-2.39 M	-2.49 M	-	-2.27 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	53.4 M	42.4 M	133 M	-	8.2 M	10 M	6.84 M	-	8.53 M	8.93 M	11.7 M	-	7.72 M	5.74 M	3.9 M	-	2.82 M	2.72 M	2.66 M	-	2.72 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General and Administrative Expenses	9.53 M	6.98 M	6 M	-	4.38 M	4.32 M	2.92 M	-	3.31 M	3.21 M	3.58 M	-	3.21 M	2.51 M	1.92 M	-	1.17 M	823 K	540 K	-	486 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency